Help 3 Month Long Stock Promotion

[Furl O. Malcontents]

INVESTMENT ALERT… 
EMERGING BIOTECH COMPANY SOON TO RELEASE GROUND BREAKING MEDICAL DEVICE 

In Vivo Medical Diagnostics, Inc (Stock Symbol OTC: IVVO) is finalizing its 
first ground-breaking portable medical device, the Prothrombin Time Monitor, 
that measures changes in the magnetic fields of blood on a molecular level. 
This is critical for patients undergoing anticoagulation therapy after heart 
attacks and strokes.
This measurement is now portable and is used in real time to achieve optimal 
medication levels, which is essential for successful treatment. IVVO has 
recently announced their joint effort with Inverness Medical Innovations a 
leading manufacturer and marketer of rapid diagnostic products in order to 
complete development of the Prothrombin Time Monitor for its clinical trials.
Prothrombin Testing is a massive market and continues to grow with projections 
in excess of $150 million in 2005 and over $500 million by 2010. IVVO is poised 
to capitalize on this significant opportunity. Don’t miss out on the near term 
upside potential in IVVO! 

INVESTMENT ANAYSIS 

In Vivo Medical Diagnostics, Inc. (Stock Symbol OTC: IVVO)
Short-Term Target: $3.00
12-Month Target: $5.00
Recommendations: Very Strong Buy
Long Term Outlook: Excellent 









Information within this email has been sent by a third party not affiliated 
wwith the company and contains "forward looking statements" within the meaning 
of Section 27A of the Securities Act of 1933 and Section 21B of the Securities 
Exchange Act of 1934. Any statements that express or involve discussions with 
respect to predictions, goals, expectations, beliefs, plans, projections, 
objectives, assumptions or future events or performance are not statements of 
historical fact and may be "forward looking statements.” Please be advised that 
nothing within this email shall constitute a solicitation or an offer to buy or 
sell any security mentioned herein. This newsletter is neither a registered 
investment advisor nor affiliated with any broker or dealer. This newsletter is 
not affiliated with In Vivo Medical Diagnostics, Inc in any way. This 
newsletter was produced and distributed by a independent third party.  All 
statements made are our express opinion only and should be treated as such. We 
may own, buy and sell any securities mentioned at any time. This report 
includes forward-looking statements within the meaning of The Private 
Securities Litigation Reform Act of 1995. These statements may include terms as 
"expect", "believe", "may", "will", "move","undervalued" and "intend" or 
similar terms. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY 
PROFILED COMPANY. You may lose money from investing in Penny Stocks.










 . . .  
  
  
  

 . . .  
  
  
  .